Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2021 Filed Apr 2, 2021 17:02 UTC Amendment |
Frimerman Debra HGeneral Counsel and Secretary
|
GrantStock Option (Right-to-Buy) · Derivative | 27,000 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001615594-21-000045 · primary_doc.xml · derivative · entry 2 Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires 2031-03-12 F2 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 12, 2021 Filed Apr 2, 2021 17:02 UTC Amendment |
Frimerman Debra HGeneral Counsel and Secretary
|
GrantCommon Stock | 19,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000045 · primary_doc.xml · nonDerivative · entry 1 Frimerman Debra H · CIK 0001353541 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,000 F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 12, 2021 Filed Apr 2, 2021 16:47 UTC Amendment |
NEUGENT CHRISTOPHER JDirector
|
GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000043 · primary_doc.xml · nonDerivative · entry 1 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,940 F1 · shares: The Restricted Stock Units reported on this Form 4 vest fully on March 12, 2022. Read SEC document |
| March 12, 2021 Filed Apr 2, 2021 21:09 UTC Amendment |
Frey TravisChief Technology Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 24,000 | $0.00 Strike: $8.05 | $0.00 |
DisclosureSEC source: 0001615594-21-000046 · primary_doc.xml · derivative · entry 2 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2031-03-12 F2 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| March 12, 2021 Filed Apr 2, 2021 21:09 UTC Amendment |
Frey TravisChief Technology Officer
|
GrantCommon Stock | 16,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-21-000046 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,400 F1 · shares: The Restricted Stock Units reported on this Form 4 vest as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:11 UTC |
Voytas Daniel FChief Science Officer
|
SaleCommon Stock | 2,513 | $4.13 | $10,387.99 |
DisclosureSEC source: 0001615594-21-000002 · primary_doc.xml · nonDerivative · entry 1 Voytas Daniel F · CIK 0001712191 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 4, 2020. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $4.05 to $4.25, inclusive. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 22:12 UTC |
Blome JamesChief Executive Officer
|
SaleCommon Stock | 4,140 | $4.17 | $17,280.77 |
DisclosureSEC source: 0001615594-21-000001 · primary_doc.xml · nonDerivative · entry 1 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,282 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on August 26, 2020. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $4.13 to $4.32, inclusive. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 22:08 UTC |
Voytas Daniel FChief Science Officer
|
SaleCommon Stock | 5,026 | $4.75 | $23,873.50 |
DisclosureSEC source: 0001615594-20-000077 · primary_doc.xml · nonDerivative · entry 1 Voytas Daniel F · CIK 0001712191 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,513 Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 22:10 UTC |
Frey TravisChief Technology Officer
|
PurchaseCommon Stock | 150 | $3.79 | $569.00 |
DisclosureSEC source: 0001615594-20-000074 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,900 F1 · shares: The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $3.79 to $3.80, inclusive. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 23:44 UTC |
Frey TravisChief Technology Officer
|
PurchaseCommon Stock | 150 | $3.26 | $489.33 |
DisclosureSEC source: 0001615594-20-000071 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,750 F1 · shares: The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $3.23 to $3.28, inclusive. Read SEC document |
| October 16, 2020 Filed Oct 20, 2020 10:05 UTC |
Cellectis S.A.10% owner
|
OtherCommon Stock | 1,250,000 | $4.00 | $5,000,000.00 |
DisclosureSEC source: 0000899243-20-028665 · doc4.xml · nonDerivative · entry 1 Cellectis S.A. · CIK 0001627281 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,963,175 F1 · kind: Purchased directly from Calyxt, Inc. in Calyxt, Inc.'s direct offering pursuant to a registration statement on Form S-3 (333-233231). The shares of common stock were purchased at the offering price. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:57 UTC |
Frey TravisChief Technology Officer
|
PurchaseCommon Stock | 150 | $5.47 | $820.10 |
DisclosureSEC source: 0001615594-20-000068 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 F1 · shares: The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $5.46 to $5.51, inclusive. Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 21:09 UTC |
Blome JamesChief Executive Officer
|
SaleCommon Stock | 4,140 | $5.59 | $23,123.56 |
DisclosureSEC source: 0001615594-20-000067 · primary_doc.xml · nonDerivative · entry 1 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,422 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on August 26, 2020. F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $5.45 to $5.74, inclusive. Read SEC document |
| September 10, 2020 Filed Sep 11, 2020 21:06 UTC |
Dumont PhilippeDirector
|
PurchaseCommon Stock | 3,000 | $5.91 | $17,728.80 |
DisclosureSEC source: 0001615594-20-000065 · primary_doc.xml · nonDerivative · entry 1 Dumont Philippe · CIK 0001712186 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,290 Read SEC document |
| September 01, 2020 Filed Sep 1, 2020 21:10 UTC |
Frey TravisChief Technology Officer
|
PurchaseCommon Stock | 150 | $5.41 | $811.01 |
DisclosureSEC source: 0001615594-20-000063 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,450 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $5.40 to $5.410, inclusive. Read SEC document |
| August 14, 2020 Filed Aug 21, 2020 21:16 UTC |
Dumont PhilippeDirector
|
PurchaseCommon Stock | 2,000 | $7.49 | $14,970.40 |
DisclosureSEC source: 0001615594-20-000061 · primary_doc.xml · nonDerivative · entry 3 Dumont Philippe · CIK 0001712186 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,290 Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 18:39 UTC |
Koschak WilliamChief Financial Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 110,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001615594-20-000054 · primary_doc.xml · derivative · entry 2 Koschak William · CIK 0001763989 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2030-08-04 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 22:17 UTC |
Nelson Kimberly K.Director
|
GrantStock Option (Right-to-Buy) · Derivative | 7,500 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001615594-20-000051 · primary_doc.xml · derivative · entry 2 Nelson Kimberly K. · CIK 0001489097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2030-08-04 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 19:00 UTC |
Frimerman Debra HGeneral Counsel
|
GrantStock Option (Right-to-Buy) · Derivative | 80,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001615594-20-000057 · primary_doc.xml · derivative · entry 2 Frimerman Debra H · CIK 0001353541 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2030-08-04 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 19:09 UTC |
Ribeill Yves JDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 25,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001615594-20-000058 · primary_doc.xml · derivative · entry 2 Ribeill Yves J · CIK 0001604049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-08-04 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 18:07 UTC |
NEUGENT CHRISTOPHER JDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 7,500 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001615594-20-000050 · primary_doc.xml · derivative · entry 2 NEUGENT CHRISTOPHER J · CIK 0001657549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2030-08-04 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 22:54 UTC |
Frey TravisChief Technology Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 80,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001615594-20-000056 · primary_doc.xml · derivative · entry 2 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2030-08-04 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 22:46 UTC |
Blome JamesChief Executive Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 175,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001615594-20-000055 · primary_doc.xml · derivative · entry 2 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2030-08-04 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 22:32 UTC |
Kozicz-Stankiewicz Anna EwaDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 5,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001615594-20-000053 · primary_doc.xml · derivative · entry 2 Kozicz-Stankiewicz Anna Ewa · CIK 0001712090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-08-04 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 22:26 UTC |
Voytas Daniel FChief Science Officer
|
GrantStock Option (Right-to-Buy) · Derivative | 65,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001615594-20-000052 · primary_doc.xml · derivative · entry 2 Voytas Daniel F · CIK 0001712191 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2030-08-04 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 21:57 UTC |
Jonathan FassbergDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 5,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001615594-20-000049 · primary_doc.xml · derivative · entry 2 Jonathan Fassberg · CIK 0001750985 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-08-04 F1 · derivative.exercise_date: Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 21:50 UTC |
Dumont PhilippeDirector
|
GrantStock Option (Right-to-Buy) · Derivative | 5,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001615594-20-000048 · primary_doc.xml · derivative · entry 2 Dumont Philippe · CIK 0001712186 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-08-04 F1 · derivative.exercise_date: The option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant. Read SEC document |
| August 03, 2020 Filed Aug 3, 2020 21:07 UTC |
Frey TravisChief Technology Officer
|
PurchaseCommon Stock | 150 | $4.36 | $653.90 |
DisclosureSEC source: 0001615594-20-000046 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $4.37 to $4.41, inclusive. Read SEC document |
| July 02, 2020 Filed Aug 21, 2020 21:20 UTC |
Kozicz-Stankiewicz Anna EwaDirector
|
SaleCommon Stock | 245 | $4.70 | $1,151.50 |
DisclosureSEC source: 0001615594-20-000062 · primary_doc.xml · nonDerivative · entry 2 Kozicz-Stankiewicz Anna Ewa · CIK 0001712090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,165 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on June 13, 2019. Read SEC document |
| July 02, 2020 Filed Aug 21, 2020 21:16 UTC |
Dumont PhilippeDirector
|
SaleCommon Stock | 236 | $4.70 | $1,109.20 |
DisclosureSEC source: 0001615594-20-000061 · primary_doc.xml · nonDerivative · entry 2 Dumont Philippe · CIK 0001712186 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,290 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on June 13, 2019. Read SEC document |
| July 01, 2020 Filed Jul 1, 2020 20:40 UTC |
Frey TravisChief Technology Officer
|
PurchaseCommon Stock | 156 | $5.04 | $786.24 |
DisclosureSEC source: 0001615594-20-000041 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,150 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. Read SEC document |
| July 01, 2020 Filed Jul 31, 2020 21:12 UTC |
Blome JamesChief Executive Officer
|
SaleCommon Stock | 3,495 | $4.65 | $16,268.18 |
DisclosureSEC source: 0001615594-20-000045 · primary_doc.xml · nonDerivative · entry 2 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,562 F2 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $4.55 to $4.9458, inclusive. Read SEC document |
| July 01, 2020 Filed Aug 3, 2020 21:13 UTC |
Choulika AndreDirector
|
SaleCommon Stock | 4,228 | $4.65 | $19,647.09 |
DisclosureSEC source: 0001615594-20-000047 · primary_doc.xml · nonDerivative · entry 1 Choulika Andre · CIK 0001712190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,815 F1 · price: The price reported in Column 4 is a weighted average. The shares were sold in multiple transactions at prices ranging from $4.55 to $4.87, inclusive. Read SEC document |
| June 29, 2020 Filed Jul 31, 2020 21:12 UTC |
Blome JamesChief Executive Officer
|
SaleCommon Stock | 2,902 | $5.01 | $14,531.77 |
DisclosureSEC source: 0001615594-20-000045 · primary_doc.xml · nonDerivative · entry 1 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,057 F1 · price: The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $4.955 to $5.03, inclusive. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:26 UTC |
Frey TravisChief Technology Officer
|
PurchaseCommon Stock | 144 | $4.43 | $637.62 |
DisclosureSEC source: 0001615594-20-000033 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,994 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $4.37 to $4.70, inclusive. Read SEC document |
| May 01, 2020 Filed May 4, 2020 18:34 UTC |
Frey TravisChief Technology Officer
|
PurchaseCommon Stock | 175 | $4.32 | $755.30 |
DisclosureSEC source: 0001615594-20-000027 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,850 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $4.31 to $4.35, inclusive. Read SEC document |
| April 02, 2020 Filed Aug 21, 2020 21:20 UTC |
Kozicz-Stankiewicz Anna EwaDirector
|
SaleCommon Stock | 245 | $2.87 | $703.15 |
DisclosureSEC source: 0001615594-20-000062 · primary_doc.xml · nonDerivative · entry 1 Kozicz-Stankiewicz Anna Ewa · CIK 0001712090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,410 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on June 13, 2019. Read SEC document |
| April 02, 2020 Filed Aug 21, 2020 21:16 UTC |
Dumont PhilippeDirector
|
SaleCommon Stock | 236 | $2.87 | $677.32 |
DisclosureSEC source: 0001615594-20-000061 · primary_doc.xml · nonDerivative · entry 1 Dumont Philippe · CIK 0001712186 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,526 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on June 13, 2019. Read SEC document |
| April 01, 2020 Filed Apr 1, 2020 20:30 UTC |
Frey TravisChief Technology Officer
|
PurchaseCommon Stock | 175 | $3.19 | $559.09 |
DisclosureSEC source: 0001615594-20-000019 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,675 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. F2 · price: The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $3.16-$3.25, inclusive. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:23 UTC |
Choulika AndreDirector
|
Tax withholdingCommon Stock | 3,690 | $2.95 | $10,902.84 |
DisclosureSEC source: 0001615594-20-000021 · primary_doc.xml · nonDerivative · entry 1 Choulika Andre · CIK 0001712190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,043 Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:21 UTC |
Blome JamesChief Executive Officer
|
Tax withholdingCommon Stock | 3,177 | $2.96 | $9,388.99 |
DisclosureSEC source: 0001615594-20-000020 · primary_doc.xml · nonDerivative · entry 1 Blome James · CIK 0001753563 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,959 Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:12 UTC |
Frey TravisChief Technology Officer
|
PurchaseCommon Stock | 200 | $6.43 | $1,286.00 |
DisclosureSEC source: 0001615594-20-000017 · primary_doc.xml · nonDerivative · entry 1 Frey Travis · CIK 0001777352 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 F1 · kind: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 11, 2019. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 10:45 UTC |
Ribeill Yves JDirector
|
SaleCommon Stock | 400 | $5.54 | $2,216.00 |
DisclosureSEC source: 0001615594-20-000016 · primary_doc.xml · nonDerivative · entry 14 Ribeill Yves J · CIK 0001604049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,030 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 4, 2018. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 10:45 UTC |
Ribeill Yves JDirector
|
SaleCommon Stock | 302 | $5.51 | $1,664.02 |
DisclosureSEC source: 0001615594-20-000016 · primary_doc.xml · nonDerivative · entry 13 Ribeill Yves J · CIK 0001604049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,430 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 4, 2018. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 10:45 UTC |
Ribeill Yves JDirector
|
SaleCommon Stock | 1,700 | $5.50 | $9,350.00 |
DisclosureSEC source: 0001615594-20-000016 · primary_doc.xml · nonDerivative · entry 12 Ribeill Yves J · CIK 0001604049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,732 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 4, 2018. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 10:45 UTC |
Ribeill Yves JDirector
|
SaleCommon Stock | 602 | $5.48 | $3,298.96 |
DisclosureSEC source: 0001615594-20-000016 · primary_doc.xml · nonDerivative · entry 11 Ribeill Yves J · CIK 0001604049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,432 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 4, 2018. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 10:45 UTC |
Ribeill Yves JDirector
|
SaleCommon Stock | 700 | $5.47 | $3,829.00 |
DisclosureSEC source: 0001615594-20-000016 · primary_doc.xml · nonDerivative · entry 10 Ribeill Yves J · CIK 0001604049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,034 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 4, 2018. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 10:45 UTC |
Ribeill Yves JDirector
|
SaleCommon Stock | 1,100 | $5.46 | $6,006.00 |
DisclosureSEC source: 0001615594-20-000016 · primary_doc.xml · nonDerivative · entry 9 Ribeill Yves J · CIK 0001604049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,734 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 4, 2018. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 10:45 UTC |
Ribeill Yves JDirector
|
SaleCommon Stock | 300 | $5.46 | $1,636.50 |
DisclosureSEC source: 0001615594-20-000016 · primary_doc.xml · nonDerivative · entry 8 Ribeill Yves J · CIK 0001604049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,834 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 4, 2018. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 10:45 UTC |
Ribeill Yves JDirector
|
SaleCommon Stock | 802 | $5.45 | $4,370.90 |
DisclosureSEC source: 0001615594-20-000016 · primary_doc.xml · nonDerivative · entry 7 Ribeill Yves J · CIK 0001604049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,134 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on December 4, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.